Influence of Left Ventricular Hypertrophy on In-Hospital Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

References

• Shrikrishna D, Astin R, Kemp PR, Hopkinson NS. Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease. Clin Sci (Lond) 2012; 123(8):487–498.
   PubMed Web of Science ®Google Scholar
• Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoffman E, et al. Pulmonary hyperinflation and left ventricular mass: the multi-ethnic study of atherosclerosis COPD study. Circulation 2013; 127(14):1503–1511, 1511e1–1511e6.
   PubMed Web of Science ®Google Scholar
• Anderson WJ, Lipworth BJ, Rekhraj S, Struthers AD, George J. Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room? Chest 2013; 143(1):91–97.
   PubMed Web of Science ®Google Scholar
• Vallabhajosyula S, Mahfood Haddad T, Sundaragiri PR, Ahmed AA, Nawaz M, Rayes HAA, et al. Role of B-type natriuretic peptide in predicting in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease: A five-year retrospective analysis. Am J Respir Crit Care Med 2015; 191:A2915.
   Google Scholar
• Edwards CW. Left ventricular hypertrophy in emphysema. Thorax 1974 Jan; 29(1):75–80.
   PubMed Web of Science ®Google Scholar
• Neilan TG, Bakker JP, Sharma B, Owens RL, Farhad H, Shah RV, et al. T1 measurements for detection of expansion of the myocardial extracellular volume in chronic obstructive pulmonary disease. Can J Cardiol 2014; 30(12):1668–1675.
   PubMed Web of Science ®Google Scholar
• Vonk-Noordegraaf A, Marcus JT, Holverda S, Roseboom B, Postmus PE. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest 2005; 127(6):1898–1903.
   PubMed Web of Science ®Google Scholar
• Inoue Y, Kawayama T, Iwanaga T, Aizawa H. High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonale. Intern Med 2009; 48(7):503–512.
   PubMed Web of Science ®Google Scholar
• Abroug F, Ouanes-Besbes L, Nciri N, Sellami N, Addad F, Hamda KB, et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 2006; 174(9):990–996.
   PubMed Web of Science ®Google Scholar
• Short PM, Anderson WJ, Elder DH, Struthers AD, Lipworth BJ. Impact of left ventricular hypertrophy on survival in chronic obstructive pulmonary disease. Lung 2015; 193(4):487–495.
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18(12):1440–1463.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28(1):1–39.e14.
   PubMed Web of Science ®Google Scholar
• Vallabhajosyula S, Kanmanthareddy A, Sundaragiri PR, Ahmed AA, Mahfood Haddad T, Rayes HAA, et al. Left ventricular hypertrophy as a predictor of B-type natriuretic peptide levels and in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease: a five-year retrospective analysis. Chest 2015; 148(4_MeetingAbstracts):677A.
   Google Scholar
• Alter P, Luetteken L, Nell C, Haid D, Kehr K, Greulich T, et al. Exercise training leads to physiological left ventricular hypertrophy in COPD. Int J Cardiol 2014; 174(1):156–157.
   PubMed Web of Science ®Google Scholar
• Alter P, Rupp H, Stoll F, Adams P, Figiel JH, Klose KJ, et al. Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure—use of the volume-based wall stress index. Int J Cardiol 2012; 157(2):233–238.
   PubMed Web of Science ®Google Scholar
• Mortensen EM, Copeland LA, Pugh MJ, Restrepo MI, de Molina RM, Nakashima B, et al. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respir Res 2009; 10:45.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Connett JE, Aaron SD, Albert RK, Bailey WC, Casaburi R, et al. COPD Clinical Research Network; Canadian Institutes of Health Research. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med 2014; 370(23):2201–2210.
   PubMed Web of Science ®Google Scholar
• Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol 2006; 47(12):2554–2560.
   PubMed Web of Science ®Google Scholar
• Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ. Effect of beta-blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ 2011; 342:d2549.
   PubMed Web of Science ®Google Scholar
• Nielsen OW, Sajadieh A. Diagnosing left ventricular hypertrophy in arterial hypertension. BMJ 2007; 335(7622):681–682.
   PubMed Web of Science ®Google Scholar
• Vizzardi E, Corda L, Sciatti E, Roca E, Redolfi S, Arici M, Pini L, et al. Echocardiographic evaluation in subjects with α1-Antitrypsin deficiency. Eur J Clin Invest 2015; 45(9):949–954.
   PubMed Web of Science ®Google Scholar
• The RO, Kerse MN, Robinson EM, Whalley GA, Connolly MJ, Doughty RN. Left ventricular geometry and all-cause mortality in advanced age. Heart Lung Circ 2015; 24(1):32–39.
   PubMed Web of Science ®Google Scholar
• Tadic M, Cuspidi C, Majstorovic A, Kocijancic V, Celic V. The relationship between left ventricular deformation and different geometric patterns according to the updated classification: findings from the hypertensive population. J Hypertens 2015; 33(9):1954–1961.
   PubMed Web of Science ®Google Scholar
• Rutten FH, Vonken EJ, Cramer MJ, Moons KG, Velthuis BB, Prakken NH, et al. Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease. Am Heart J. 2008 Sep; 156(3):506–512.
   PubMed Web of Science ®Google Scholar
• Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y, et al. Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 2011; 8(7):514–522.
   PubMed Web of Science ®Google Scholar
• Jorgensen K, Muller MF, Nel J, Upton RN, Houltz E, Ricksten SE. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 2007; 131(4):1050–1057.
   PubMed Web of Science ®Google Scholar